DALLAS--(BUSINESS WIRE)--Aug. 24, 2006--Capital Senior Living Corporation (NYSE:CSU) and GE Healthcare Financial Services today announced the formation of a new joint venture that has completed a $38.2 million acquisition of three senior housing communities in the metropolitan Indianapolis area.
business unit
tags
CHALFONT ST. GILES, England--(BUSINESS WIRE)--Aug. 22, 2006--GE Healthcare, a subsidiary of the General Electric Company (NYSE:GE) and Cord Blood Registry (CBR) announced today that CBR is automating the key production steps for their cord blood stem cell units using GE Healthcare's AutoXpress(TM) System. AutoXpress is an automated, functionally-closed, sterile system that harvests mononuclear cell fraction from cord blood, capturing the stem cell rich portion of the blood into a final volume of product that is defined by the user.
business unit
tags
CHALFONT ST GILES, England--(BUSINESS WIRE)--July 31, 2006--GE Healthcare, a unit of General Electric Company (NYSE:GE) today announced that GE Healthcare has exercised the exclusive option to license PhotoCure's product Hexvix(R) (hexaminolevulinate), an optical molecular imaging agent intended for the diagnosis and monitoring of bladder cancer, for the US market. This is an extension of the agreement signed earlier this year that afforded GE Healthcare exclusive global rights outside of the Nordic region to market and distribute PhotoCure's product Hexvix.
business unit
tags
VIENNA, Va.--(BUSINESS WIRE)--July 24, 2006--MobileAccess Networks, an enterprise wireless innovator, and GE Healthcare announced today the availability of Wireless Medical Telemetry Service (WMTS) on GE's Enterprise Access solution. Developed to help hospitals seamlessly bring their entire portfolio of wireless services and applications together on a single infrastructure, GE's Enterprise Access enables healthcare organizations to harness the power of next-generation wireless computing throughout their facilities.
business unit
tags
PISCATAWAY, N.J.--(BUSINESS WIRE)--July 10, 2006--The Translational Genomics Research Institute (TGen) and GE Healthcare (NYSE:GE) announced today a strategic alliance designed to apply advanced cellular genomics technologies and strategies to improve and accelerate the discovery and development of new drugs. This research collaboration will support the mutual goals of translating basic genomic research into early health solutions for some of the most urgent problems facing healthcare today.
business unit
tags
SINGAPORE--(BUSINESS WIRE)--June 23, 2006--Fonterra, a global dairy business and expert in nutritional dairy products, and GE Healthcare's Lunar business, the industry leader in bone assessment technologies, today announced a partnership to tackle the growing global health problem of osteoporosis head-on using Fonterra's ANLENE(TM) bone health products and GE Healthcare's bone mineral density technology.
business unit
tags
--(BUSINESS WIRE)--The clinical trial, sponsored by GE Healthcare, will test a new imaging agent for cancer detection on more than two-dozen breast cancer patients. This research will track the process of angiogenesis, which is the growth of new blood vessels in the body. This experimental contrast agent could help doctors monitor new vessel production, and identify a tumor's exact dimensions. If the trial is successful, researchers say the results could be "groundbreaking" for cancer patients.